3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine,
teneligliptin,
Teneligliptin,
760937-92-6,
UNII-28ZHI4CF9C,
Teneligliptin [INN],
28ZHI4CF9C,
Teneligliptin hydrobromide,
CHEMBL2147777,
MP-513,
Teneligliptin (INN),
[(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone,
C22H30N6OS,
{(2s,4s)-4-[4-(3-Methyl-1-Phenyl-1h-Pyrazol-5-Yl)piperazin-1-Yl]pyrrolidin-2-Yl}(1,3-Thiazolidin-3-Yl)methanone,
906093-29-6,
Teneli,
SCHEMBL161778,
GTPL9906,
CHEBI:136042,
WGRQANOPCQRCME-PMACEKPBSA-N,
MP513,
4095AH,
BDBM50391565,
MFCD13195565,
ZINC36520254,
AKOS025401965,
API0014166,
CS-0882,
DB11950,
SB16807,
compound 8g [PMID: 22959556],
NCGC00378896-02,
AC-27649,
AN-16687,
HY-14806,
SC-93290,
D08616,
W-5574,
937T926,
(R)-di-tert-butyl 2,3-dihydro-1H-pyrrole-1,2-dicarboxylate,
((2S,4S)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-yl)(thiazolidin-3-yl)methanone,
[(2S,4S)-4-[4-(5-methyl-2-phenyl-pyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-thiazolidin-3-yl-methanone,
3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine,
M51,
Methanone,[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinyl-,
tenelia,
D07EPV,
Teneligliptin hydrobromide hydrate,
CS-T-43286,
CID11949652,
CID 11949652,
A3865,